BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12767163)

  • 1. Finding multiactivity substructures by mining databases of drug-like compounds.
    Sheridan RP
    J Chem Inf Comput Sci; 2003; 43(3):1037-50. PubMed ID: 12767163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current parallel chemistry principles and practice: application to the discovery of biologically active molecules.
    Edwards PJ
    Curr Opin Drug Discov Devel; 2009 Nov; 12(6):899-914. PubMed ID: 19894197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying data mining techniques to library design, lead generation and lead optimization.
    Weaver DC
    Curr Opin Chem Biol; 2004 Jun; 8(3):264-70. PubMed ID: 15183324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calculating similarities between biological activities in the MDL Drug Data Report database.
    Sheridan RP; Shpungin J
    J Chem Inf Comput Sci; 2004; 44(2):727-40. PubMed ID: 15032555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are target-family-privileged substructures truly privileged?
    Schnur DM; Hermsmeier MA; Tebben AJ
    J Med Chem; 2006 Mar; 49(6):2000-9. PubMed ID: 16539387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A similarity-based data-fusion approach to the visual characterization and comparison of compound databases.
    Medina-Franco JL; Maggiora GM; Giulianotti MA; Pinilla C; Houghten RA
    Chem Biol Drug Des; 2007 Nov; 70(5):393-412. PubMed ID: 17927720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of biological targets for compounds using multiple-category Bayesian models trained on chemogenomics databases.
    Nidhi ; Glick M; Davies JW; Jenkins JL
    J Chem Inf Model; 2006; 46(3):1124-33. PubMed ID: 16711732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for designing GPCR-focused libraries and screening sets.
    Jimonet P; Jäger R
    Curr Opin Drug Discov Devel; 2004 May; 7(3):325-33. PubMed ID: 15216936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective optimization of side activities: another way for drug discovery.
    Wermuth CG
    J Med Chem; 2004 Mar; 47(6):1303-14. PubMed ID: 14998318
    [No Abstract]   [Full Text] [Related]  

  • 10. Fragment formal concept analysis accurately classifies compounds with closely related biological activities.
    Krüger F; Lounkine E; Bajorath J
    ChemMedChem; 2009 Jul; 4(7):1174-81. PubMed ID: 19384901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based generation of viable leads from small combinatorial libraries.
    Laird ER; Blake JF
    Curr Opin Drug Discov Devel; 2004 May; 7(3):354-9. PubMed ID: 15216940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the scaffold diversity of screening libraries.
    Krier M; Bret G; Rognan D
    J Chem Inf Model; 2006; 46(2):512-24. PubMed ID: 16562979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural product-like synthetic libraries.
    Thomas GL; Johannes CW
    Curr Opin Chem Biol; 2011 Aug; 15(4):516-22. PubMed ID: 21684804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancing chemistry and biology through diversity-oriented synthesis of natural product-like libraries.
    Shang S; Tan DS
    Curr Opin Chem Biol; 2005 Jun; 9(3):248-58. PubMed ID: 15939326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Informative library design as an efficient strategy to identify and optimize leads: application to cyclin-dependent kinase 2 antagonists.
    Bradley EK; Miller JL; Saiah E; Grootenhuis PD
    J Med Chem; 2003 Sep; 46(20):4360-4. PubMed ID: 13678414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural products and combinatorial chemistry: back to the future.
    Ortholand JY; Ganesan A
    Curr Opin Chem Biol; 2004 Jun; 8(3):271-80. PubMed ID: 15183325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural product-like libraries based on non-aromatic, polycyclic motifs.
    Messer R; Fuhrer CA; Häner R
    Curr Opin Chem Biol; 2005 Jun; 9(3):259-65. PubMed ID: 15939327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formal concept analysis for the identification of molecular fragment combinations specific for active and highly potent compounds.
    Lounkine E; Auer J; Bajorath J
    J Med Chem; 2008 Sep; 51(17):5342-8. PubMed ID: 18698757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug evolution concept in drug design: 1. Hybridization method.
    Lazar C; Kluczyk A; Kiyota T; Konishi Y
    J Med Chem; 2004 Dec; 47(27):6973-82. PubMed ID: 15615546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mining statistically significant molecular substructures for efficient molecular classification.
    Ranu S; Singh AK
    J Chem Inf Model; 2009 Nov; 49(11):2537-50. PubMed ID: 19928835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.